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The distinguished American neurosurgeon, Harvey Cushing, should take the credit for being the first person to suggest that the measurement of blood pressure be carried out routinely in all patients, although, sadly, this is an ideal that has still not been achieved. 2 There is an extensive literature on the sources of error encountered with blood pressure measurement and these can be neatly divided into those that are associated with the observer, with his or her bias or inaccuracy, the manometer itself which may be inaccurate or damaged and the cuff which may be the wrong size. 3 Tests of blood pressure measurers have shown depressing results and there are also many studies examining blood pressure machines and cuffs which are equally woeful. 4, 5 This prompted the St George's Hospital group to suggest that as conventional mercury sphygmomanometers are so bad they should be abolished in favour of electronic equipment as soon as possible. 6 Meanwhile, there are increasing anxieties about the possible hazards of mercury to the environment. 7 Metallic mercury and inorganic mercury salts are probably not particularly toxic but there is a concern about organic mercury which might, in theory, enter the food chain. Very little mercury is recycled and there must be some concern about the amount of mercury from broken sphygmomanometers, and also thermometers, under the floorboards of some of our older and more ramshackle hospitals. It is because of these worries that a new European Union directive will prohibit the use of mercury in sphygmomanometer and thermometers. 8 Advances in technology now mean it is possible to measure blood pressure using automatic or semiautomatic devices without the need for a mercury manometer. It has become clear, however, that many of these machines are inaccurate and the British Hypertension Society (BHS) as well as the American Association for Medical Instrumentation (AAMI) have both issued guidelines on how the blood pressure machines should be assessed. 9 By any criteria a very large proportion of the currently available automatic and semi-automatic machines were found to be unacceptable. It is interesting to note that some manufacturers have marketed these machines without any apparent effort to ensure that they are accurate. Presumably it was argued that because the machine should be accurate therefore it will be accurate. Thus field trials were not conducted. Several Health Authorities in the UK have proudly opted to go 'mercury free' and have bulk purchased automatic machines that are frankly inaccurate. Others have opted to bulk purchase cheaper aneroid manometers despite their well-recognised tendency to become inaccurate with the passage of time.
One of the few automatic blood pressure measuring systems which has passed both BHS and AAMI criteria is the OMRON HEM 705 CP. 10 This desktop model together with printer has therefore been purchased by a great many blood pressure units and research workers. It is the machine currently being used in the Anglo-Scandinavian Cardiac Outcome Trial (ASCOT) and the sales must be enormous. General practitioners in Britain have been mailed a leaflet advertising the OMRON 705 CP and the World Hypertension League (WHL) has circulated a leaflet on blood pressure measurement which specifically mentions the HEM 705 CP.
Most blood pressure machines do not really need a printer and for that reason the OMRON M4 appar-Journal of Human Hypertension atus has become available and can be used by doctors, nurses and patients to monitor blood pressure. Many clinicians hoped that one could extrapolate from the 705 CP to the M4, both machines being made by the same company.
An alarming paper is published in this month's issue of the Journal of Human Hypertension.
11 Naschitz and co-workers from Israel have developed a simplified method of testing the accuracy of automatic blood pressure devices and when they had turned their attention to the OMRON M4 they have come up with some surprising findings. 12 They concluded that the M4 device did not meet the criteria of the British Hypertension Society and could not be recommended for clinical use.
Meanwhile how confident are we of the OMRON HEM 705 CP? It is the experience of many clinicians that this machine sometimes turns up isolated rogue readings which are totally improbable and not confirmed 30 seconds later. Sometimes the 705 CP seems to go on strike and flashes up a somewhat disconcerting 'E'. The choice of cuffs is limited to two, the larger one being designed with the assumption that obese people also have longer arms. One of our cuffs spontaneously tore apart whilst in use.
One of the senior research nurses in our department was so exasperated with the OMRON apparatus that she has abandoned it and now maintains that she would much rather measure blood pressure with a well-maintained mercury manometer, using the strict criteria laid down in the BHS. The advantages of an automatic system are however that one can, effortlessly, take several bias-free blood pressure readings and obtain results that are more basal than a one-off reading in patients who have just walked into the clinic room. It is not uncommon for patients systolic blood pressures to fall by 25 mm Hg or more over 5 or 6 min during a consultation. The clinician meanwhile can check the case notes, make sure that the ECG has been done, the blood test results are filed and may be have the time to think out a more rational blood pressure lowering regime. The convenience is undeniable but possibly with the OMRON M4 the clinician is being misled by blood pressure readings which are inaccurate. Can we recommend this apparatus to our patients? What should blood pressure experts say when contacted by clinicians and administrators enquiring about the best machines to purchase, often on a large scale. It would be interesting to know what the readership of this journal think.
Meanwhile on a longer term basis there may be light at the end of the tunnel. There is an increasing body of opinion that the diastolic blood pressure is no longer worth measuring. 13 Epidemiological studies, echocardiographic studies, randomised controlled trials and investigations into the vascular biology of isolated systolic hypertension and systodiastolic hypertension strongly suggest that systolic blood pressure is more important than the diastolic pressure. Indeed the diastolic blood pressure may provide little information after the systolic blood pressure has been taken into account. Central to this argument of course is the truth or otherwise of the observation that isolated diastolic hypertension, a rare syndrome, does not carry a poor prognosis. If this is the case and we do decide that diastolic pressure does not need to be measured, then the systolic blood pressure alone would become the gold standard. The technology of automatic and semi-automatic blood pressure monitors could be greatly simplified simply to detect the pressure within the arm cuff when the first jet of blood passes under it. With mercury manometers one could therefore measure the systolic blood pressure simply by palpation of the brachial artery. Things would indeed be a great deal simpler and doctors and nurses could spend less time with stethoscopes in their ears.
More than a century after the invention of the first usable mercury manometer, blood pressure measurement seems to be in more chaos than ever before. If the experts are behaving like headless chickens what are general practitioners, general physicians and nurses meant to do?
